Immunotech Biopharm Ltd's total assets for Q4 2025 were ¥603.20M, an increase of 23.38% from the previous quarter. HK:6978 total liabilities were ¥569.01M for the fiscal quarter, a -10.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.